161 related articles for article (PubMed ID: 6751336)
1. Serum pepsinogen I in rheumatic diseases. Reduced levels in Sjögren's syndrome.
Maury CP; Räsänen V; Teppo AM; Helve T; Wegelius O
Arthritis Rheum; 1982 Sep; 25(9):1059-63. PubMed ID: 6751336
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.
Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
Arthritis Res Ther; 2004; 6(2):73-4. PubMed ID: 15059267
[No Abstract] [Full Text] [Related]
3. Serum beta-2-microglobulin in Sjögren's syndrome.
Ström T; Evrin PE; Karlsson A
Scand J Rheumatol; 1978; 7(2):97-100. PubMed ID: 81519
[TBL] [Abstract][Full Text] [Related]
4. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases.
Nozawa K; Kayagaki N; Tokano Y; Yagita H; Okumura K; Hasimoto H
Arthritis Rheum; 1997 Jun; 40(6):1126-9. PubMed ID: 9182923
[TBL] [Abstract][Full Text] [Related]
5. Reflections in the assessment of secondary Sjogren's syndrome.
Hernández-Molina G; Avila-Casado C; Sánchez-Guerrero J
Rheumatology (Oxford); 2011 Aug; 50(8):1519-21. PubMed ID: 21672968
[No Abstract] [Full Text] [Related]
6. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases.
al-Janadi M; al-Balla S; al-Dalaan A; Raziuddin S
J Clin Immunol; 1993 Jan; 13(1):58-67. PubMed ID: 8445045
[TBL] [Abstract][Full Text] [Related]
7. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.
Krejsek J; Slezák R; Kopecky O; Derner V; Andrys C
Clin Rheumatol; 1997 Mar; 16(2):149-53. PubMed ID: 9093796
[TBL] [Abstract][Full Text] [Related]
8. Serum beta 2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus.
Maury CP; Helve T; Sjöblom C
Rheumatol Int; 1982; 2(4):145-9. PubMed ID: 6189175
[TBL] [Abstract][Full Text] [Related]
9. [Cryoglobulinemia in rheumatic diseases].
Baranauskaĭte AA; Nasonov EL; Solov'ev SK
Klin Med (Mosk); 1991 Jun; 69(6):23-32. PubMed ID: 1774903
[No Abstract] [Full Text] [Related]
10. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
Singapore Med J; 2007 Sep; 48(9):847-9. PubMed ID: 17728967
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteins.
Yokota SI; Hirata D; Minota S; Higashiyama T; Kurimoto M; Yanagi H; Yura T; Kubota H
Cell Stress Chaperones; 2000 Oct; 5(4):337-46. PubMed ID: 11048656
[TBL] [Abstract][Full Text] [Related]
12. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
13. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
[No Abstract] [Full Text] [Related]
14. [Salivary and serum beta 2-microglobulin in the diagnosis of primary Sjögren's syndrome].
Bianucci G; Campana G; Bongi SM; Palermo C; D'Agata A
Minerva Med; 1992 Nov; 83(11):705-13. PubMed ID: 1461541
[TBL] [Abstract][Full Text] [Related]
15. Circulating soluble CD30 levels in primary Sjögren's syndrome, SLE and rheumatoid arthritis.
Ichikawa Y; Yoshida M; Yamada C; Horiki T; Hoshina Y; Uchiyama M
Clin Exp Rheumatol; 1998; 16(6):759-60. PubMed ID: 9844777
[No Abstract] [Full Text] [Related]
16. Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sjögren's syndrome.
Duda S; Witte T; Stangel M; Adams J; Schmidt RE; Baerlecken NT
Immunol Res; 2017 Dec; 65(6):1099-1102. PubMed ID: 29138979
[No Abstract] [Full Text] [Related]
17. Serum angiotensin converting enzyme in Sjogren's syndrome--a case report and study of 21 further cases.
Machin ND; Chard MD; Paice EW
Postgrad Med J; 1984 Apr; 60(702):270-1. PubMed ID: 6328467
[TBL] [Abstract][Full Text] [Related]
18. Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases.
Miyachi K; Iwai M; Asada K; Saito I; Hankins R; Mikoshiba K
Mod Rheumatol; 2007; 17(2):137-43. PubMed ID: 17437169
[TBL] [Abstract][Full Text] [Related]
19. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
20. Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome.
Lee SJ; Oh HJ; Choi BY; Jang YJ; Lee JY; Park JK; Song YW
J Immunol Res; 2016; 2016():5781070. PubMed ID: 28074193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
